{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.0/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Midazolam",
            "Path": "https://raw.githubusercontent.com/sfrechen/Midazolam-Model/master/Midazolam-Model.json",
            "BuildingBlocks": [
                {
                    "Type": "Compound",
                    "Name": "Midazolam",
                    "Project": "Midazolam"
                },
                {
                    "Type": "Formulation",
                    "Name": "Oral solution",
                    "Project": "Midazolam"
                },
                {
                    "Type": "Formulation",
                    "Name": "Tablet (Dormicum)",
                    "Project": "Midazolam"
                }
            ]
        },
        {
            "Id": "Erythromycin-Model",
            "Path": "https://raw.githubusercontent.com/AndreDlm/Erythromycin-Model/master/Erythromycin-Model.json",
            "BuildingBlocks": [
                {
                    "Type": "Compound",
                    "Name": "Erythromycin",
                    "Project": "Erythromycin"
                },
                {
                    "Type": "Formulation",
                    "Name": "Erythromycin_Weibull_filmtablet",
                    "Project": "Erythromycin"
                },
                {
                    "Type": "Formulation",
                    "Name": "Erythromycin_Weibull_enteric-coated-tablet",
                    "Project": "Erythromycin"
                },
                {
                    "Type": "Formulation",
                    "Name": "Erythromycin_Weibull_enteric-coated-pellets",
                    "Project": "Erythromycin"
                }
            ]
        },
        {
            "Id": "Erythromycin-Midazolam-DDI",
            "Path": "https://raw.githubusercontent.com/AndreDlm/Erythromycin-Midazolam-DDI/master/Erythromycin-Midazolam-DDI.json",
            "BuildingBlocks": [
                {
                    "Type": "Individual",
                    "Name": "Okudaira2007",
                    "Project": "Midazolam"
                },
                {
                    "Type": "Individual",
                    "Name": "Olkkola1993",
                    "Project": "Midazolam"
                },
                {
                    "Type": "Individual",
                    "Name": "Swart2002",
                    "Project": "Midazolam"
                },
                {
                    "Type": "Individual",
                    "Name": "Zimmermann1996",
                    "Project": "Midazolam"
                }
            ],
            "SimulationParameters": [
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "DDI_Control_Okudaira2007_EM0",
                        "DDI_Control_Olkkola1993_IV",
                        "DDI_Control_Olkkola1993_Oral",
                        "DDI_Control_Swart2002",
                        "DDI_Control_Zimmermann1996",
                        "DDI_Treatment_Okudaira2007_EM2",
                        "DDI_Treatment_Okudaira2007_EM4",
                        "DDI_Treatment_Okudaira2007_EM7",
                        "DDI_Treatment_Olkkola1993_IV",
                        "DDI_Treatment_Olkkola1993_Oral",
                        "DDI_Treatment_Swart2002",
                        "DDI_Treatment_Zimmermann1996"
                    ]
                }
            ]
        }
    ],
    "ObservedDataSets": [
        {
            "Id": "DDI Ratios",
            "Path": "https://raw.githubusercontent.com/sfrechen/Database-for-observed-data/master/DDI.csv",
            "Type": "DDIRatio"
        }
    ],
    "Plots": {
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AxesSettings": {
            "ComparisonTimeProfile": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "µg/ml",
                    "Dimension": "Concentration (mass)",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Unit": "µg/ml",
                    "Dimension": "Concentration (mass)",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "µg/ml",
                    "Dimension": "Concentration (mass)",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "PKRatioPlots": [
                {
                    "Unit": "year(s)",
                    "Dimension": "Age",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "AllPlots": [
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 0.001 mg (5 min)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (2 min)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (30 min)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (bolus)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 0.075 mg/kg (1 min)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 0.15 mg/kg (bolus)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 1 mg (5 min)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 1 mg (bolus)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 2 mg (bolus)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 5 mg (30 sec)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "iv 5 mg (bolus)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 0.003 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 0.075 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 0.075 mg/kg (syrup)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 10 mg (tablet)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 2 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 20 mg (tablet)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 3 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 4 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 40 mg (tablet)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 5 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 6 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (tablet)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 10 mg (solution)"
            },
            {
                "SectionId": 13,
                "Project": "Midazolam",
                "Simulation": "po 2.5 mg (solution)"
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_1000mg_Huppertz2011",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_125mg_Austin1980",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_125mg_Sun2010",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_250mg_3min_Austin1980",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_250mg_Austin1980",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_300mg_Pasic1987",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_500mg_Austin1980",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_500mg_Barre1987",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_900mg_Austin1980",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "1000mg_Josefsson1982a_pellets",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Birkett1990",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Josefsson1982a_pellets",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Josefsson1982a_pellets",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Kivistö1997_pellets_MD",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Schreiner1984_pellets",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Yakatan1980_base_MD",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_DiSanto1981",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Kroboth1982",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Posti1982_E",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "1000mg_Miglioli1990_MD",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Yakatan1980_stearate",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Yakatan1980_stearate_MD",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Iliopoulou1982_MD",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Josefsson1982a",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Kavi1988",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Malmborg1978_MD",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Posti1983_A1",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Posti1983_A2/RN",
                "SectionId": 18
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Schreiner1984_stearate",
                "SectionId": 18
            }
        ],
        "GOFMergedPlots": [
            {
                "SectionId": 14,
                "Title": "Midazolam concentration in plasma/blood",
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "Midazolam iv",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.001 mg (5 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hohmann 2015 - iv 0.001 mg - Midazolam - IV - 0.001 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.05 mg/kg (2 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.05 mg/kg (2 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Saari 2006 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.05 mg/kg (2 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.05 mg/kg (30 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.05 mg/kg (30 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.05 mg/kg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.075 mg/kg (1 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.075 mg/kg (1 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Allonen 1981 - iv - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.15 mg/kg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. A.St. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.15 mg/kg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. CH.B. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.15 mg/kg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. E.Sch. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.15 mg/kg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. K.M. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.15 mg/kg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. O.A. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 0.15 mg/kg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. R.H. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 1 mg (5 min)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hohmann 2015 - iv 1 mg - Midazolam - IV - 1 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 1 mg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 1 mg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 1 mg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 1 mg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 2 mg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 2 mg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Darwish 2008 - iv - Midazolam - IV - 2 mg - Plasma - agg. (n=24)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 5 mg (30 sec)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schwagmeier 1998 - iv administration - Midazolam - IV - 5 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "iv 5 mg (bolus)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Smith 1981 - iv 5 mg - Midazolam - IV - 5 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            }
                        ]
                    },
                    {
                        "Caption": "Midazolam po",
                        "Symbol": "Asterisk",
                        "OutputMappings": [
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 0.003 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hohmann 2015 - po 0.003 mg - Midazolam - PO - 0.003 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 0.075 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 0.075 mg/kg (syrup)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 10 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 10 mg - Indiv. R.H. - Midazolam - PO - 10 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 10 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 10 mg - Indiv. O.A. - Midazolam - PO - 10 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 10 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 10 mg - Indiv. K.M. - Midazolam - PO - 10 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 10 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Smith 1981 - oral tablet 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 15 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bornemann 1986 - fasting condition - Midazolam - PO - 15 mg - Plasma - agg. (n=18)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 15 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 15 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 15 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 15 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 15 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 15 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Allonen 1981 - oral - Midazolam - PO - 15 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 2 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 20 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. R.H. - Midazolam - PO - 20 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 20 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. O.A. - Midazolam - PO - 20 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 20 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. K.M. - Midazolam - PO - 20 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 20 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. E.Sch. - Midazolam - PO - 20 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 20 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. CH.B. - Midazolam - PO - 20 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 20 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. A.St. - Midazolam - PO - 20 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 3 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hohmann 2015 - po 3 mg - Midazolam - PO - 3 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 3 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 3 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 4 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 4 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 40 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 40 mg - Indiv. E.Sch. - Midazolam - PO - 40 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 40 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 40 mg - Indiv. CH.B. - Midazolam - PO - 40 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 40 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Heizmann 1983 - po 40 mg - Indiv. A.St. - Midazolam - PO - 40 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 5 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Darwish 2008 - oral - Midazolam - PO - 5 mg - Plasma - agg. (n=24)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 5 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Tham 2006 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=28)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 6 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Greenblat 2003 - Control (Perpetrator Placebo) - Midazolam - PO - 6 mg - Plasma - agg. (n=25)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 7.5 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2008a - Control pre-Kava kava (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2008a - Control pre-Goldenseal (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2006 - Control pre-Milk thistle (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2006 - Control pre-Black cohosh (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 8 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 7.5 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 7.5 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 7.5 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 7.5 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 7.5 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Saari 2006 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 7.5 mg (tablet)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 10 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Smith 1981 - oral solution 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Midazolam",
                                "Simulation": "po 2.5 mg (solution)",
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            }
                        ]
                    }
                ]
            },
            {
                "SectionId": 19,
                "Title": "Erythromycin concentration in plasma",
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "IV (model building)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_125mg_Sun2010",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Sun 2010 - Subjects with normal renal function - Erythromycin - IV - 125 mg - Plasma - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_250mg_3min_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 250 mg over 3 min (Regimen 1) - Erythromycin - IV - 250 mg - Serum - agg. (n=24)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_300mg_Pasic1987",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Pasic 1987 - Without oral theophylline co-administration - Erythromycin - IV - 300 mg - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_500mg_Barre1987",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Barre 1987 - 500 mg over 30 min, total concentrations - Erythromycin - IV - 500 mg - Serum - agg. (n=6)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_500mg_Barre1987",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Barre 1987 - 500 mg over 30 min, unbound concentrations - Erythromycin - IV - 500 mg - Serum - agg. (n=6)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, stearate (model building)",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "1000mg_Miglioli1990_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Miglioli 1990 - First dose, young subjects - Erythromycin - PO - 1 g - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "1000mg_Miglioli1990_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Miglioli 1990 - Seventh dose, young subjects - Erythromycin - PO - 1 g - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Yakatan1980_stearate",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yakatan 1980 - Stearate, single dose - Erythromycin - PO - 250 mg - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Yakatan1980_stearate_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yakatan 1980 - Stearate, five doses, every 6 h - Erythromycin - PO - 250 mg - Serum - agg. (n=24)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Malmborg1978_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malmborg 1978 - Single dose after overnight fast - Erythromycin - PO - 500 mg - Plasma - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Malmborg1978_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malmborg 1978 - Single dose before standardized breakfast - Erythromycin - PO - 500 mg - Plasma - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Malmborg1978_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malmborg 1978 - Day 7, every 8 h - Erythromycin - PO - 500 mg - Plasma - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1983_A1",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation A1 (film-coated tabet, ery stearate), fasted - Erythromycin - PO - 500 mg - Serum - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1983_A2/RN",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation A2 (film-coated tabet, ery stearate), study 2 - Erythromycin - PO - 500 mg - Serum - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1983_A2/RN",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation RN (film-coated tabet, ery stearate), study 2 - Erythromycin - PO - 500 mg - Serum - agg. (n=12)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "PO enteric coated tablet, base (model building)",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_DiSanto1981",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DiSanto 1981 - Overnight fast, enteric-coated erythromycin tablets (study 1) - Erythromycin - PO - 500 mg - Serum - agg. (n=21)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_DiSanto1981",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DiSanto 1981 - 2h fast, enteric-coated erythromycin tablets (study 2) - Erythromycin - PO - 500 mg - Serum - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1982_E",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation E (enteric-coated tablets, ery base), fasted - Erythromycin - PO - 500 mg - Serum - agg. (n=15)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "PO enteric coated capsule, base pellets (model building)",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Birkett1990",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Birkett 1990 - 250 mg erythromycin, single dose - Erythromycin - PO - 250 mg - Plasma - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Birkett1990",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Birkett 1990 - 250 mg erythromycin, multiple dose - Erythromycin - PO - 250 mg - Plasma - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Kivistö1997_pellets_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kivistö 1997 - with Perpetrator (Erythromycin) - Erythromycin - PO - 500 mg - Plasma - agg. (n=8)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "IV",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_1000mg_Huppertz2011",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Huppertz 2011 - Treatment group, erythromycin - Erythromycin - IV - 1000 mg - Plasma - agg. (n=12)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_125mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 125 mg over 15 min (Regimen 2) - Erythromycin - IV - 125 mg - Serum - agg. (n=5)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_250mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 250 mg over 15 min (Regimen 2) - Erythromycin - IV - 250 mg - Serum - agg. (n=5)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_500mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 500 mg over 15 min (Regimen 2) - Erythromycin - IV - 500 mg - Serum - agg. (n=4)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_900mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 900 mg over 15 min (Regimen 2) - Erythromycin - IV - 900 mg - Serum - agg. (n=3)",
                                "Color": "#b2df8a"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, stearate",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Iliopoulou1982_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Iliopoulou 1982 - fourth day, before theophylline administration - Erythromycin - PO - 500 mg - Serum - agg. (n=6)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Josefsson1982a",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin stearate 500 mg (base equivalent) - Erythromycin - PO - 500 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Kavi1988",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kavi 1988 - Serum levels - Erythromycin - PO - 500 mg - Serum - agg. (n=6)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_stearate",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part I, stearate tablet - Erythromycin - PO - 500 mg - Serum - agg. (n=14)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_stearate",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part II, stearate tablet - Erythromycin - PO - 500 mg - Serum - agg. (n=10)",
                                "Color": "#b2df8a"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, base",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Yakatan1980_base_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yakatan 1980 - Base, five doses, every 6 h - Erythromycin - PO - 250 mg - Serum - agg. (n=24)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Kroboth1982",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kroboth 1982 - Normal subjects - Erythromycin - PO - 500 mg - Serum - agg. (n=6)",
                                "Color": "#b2df8a"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, base pellets",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "1000mg_Josefsson1982a_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin base 1000 mg - Erythromycin - PO - 1000 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Josefsson1982a_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin base 250 mg - Erythromycin - PO - 250 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Josefsson1982a_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin base 500 mg - Erythromycin - PO - 500 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part I, base (enteric-coated pellets) - Erythromycin - PO - 500 mg - Serum - agg. (n=14)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part II, base (enteric-coated pellets) - Erythromycin - PO - 500 mg - Serum - agg. (n=10)",
                                "Color": "#b2df8a"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [
            {
                "SectionId": 20,
                "Title": "Okudaira 2007",
                "SimulationDuration": 22,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Control_Okudaira2007_EM0",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without erythromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Treatment_Okudaira2007_EM2",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Okudaira 2007 - EM 2 with Perpetrator (Erythromycin) - Midazolam - PO - 2.5 mg - Plasma - agg. (n=12)",
                        "StartTime": 25,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment with erythromycin for 2 days",
                        "Symbol": "Square"
                    },
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Treatment_Okudaira2007_EM4",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Okudaira 2007 - EM 4 with Perpetrator (Erythromycin) - Midazolam - PO - 2.5 mg - Plasma - agg. (n=12)",
                        "StartTime": 73,
                        "TimeUnit": "h",
                        "Color": "#d6604d",
                        "Caption": "Treatment with erythromycin for 4 days",
                        "Symbol": "Triangle"
                    },
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Treatment_Okudaira2007_EM7",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Okudaira 2007 - EM 7 with Perpetrator (Erythromycin) - Midazolam - PO - 2.5 mg - Plasma - agg. (n=12)",
                        "StartTime": 145,
                        "TimeUnit": "h",
                        "Color": "#d6604d",
                        "Caption": "Treatment with erythromycin for 7 days",
                        "Symbol": "Triangle"
                    }
                ]
            },
            {
                "SectionId": 20,
                "Title": "Olkkola 1993 IV",
                "SimulationDuration": 18,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Control_Olkkola1993_IV",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without erythromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Treatment_Olkkola1993_IV",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Olkkola 1993 - iv with Perpetrator (Erythromycin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)",
                        "StartTime": 128,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with erythromycin)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionId": 20,
                "Title": "Olkkola 1993 Oral",
                "SimulationDuration": 18,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Control_Olkkola1993_Oral",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without erythromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Treatment_Olkkola1993_Oral",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Olkkola 1993 - po with Perpetrator (Erythromycin) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                        "StartTime": 128,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with erythromycin)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionId": 20,
                "Title": "Swart 2002",
                "SimulationDuration": 4,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Control_Swart2002",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without erythromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Treatment_Swart2002",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Swart 2002 - day 10 Control with Perpetrator (Erythromycin) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)",
                        "StartTime": 96,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with erythromycin)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionId": 20,
                "Title": "Zimmermann 1996",
                "SimulationDuration": 24,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Control_Zimmermann1996",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without erythromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Erythromycin-Midazolam-DDI",
                        "Simulation": "DDI_Treatment_Zimmermann1996",
                        "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Zimmermann 1996 - with Perpetrator (Erythromycin) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                        "StartTime": 97.5,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with erythromycin)",
                        "Symbol": "Square"
                    }
                ]
            }
        ],
        "DDIRatioPlots": [
            {
                "SectionId": 5,
                "Title": "CYP3A4 DDI",
                "PKParameter": "AUC|CMAX",
                "PlotType": "predictedVsObserved|residualsVsObserved",
                "Groups": [
                    {
                        "Caption": "Erythromycin+Midazolam (Midazolam IV)",
                        "Color": "#FF0000",
                        "Symbol": "Square",
                        "DDIRatios": [
                            {
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 420,
                                "SimulationControl": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Control_Swart2002",
                                    "StartTime": 0,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Treatment_Swart2002",
                                    "StartTime": 96,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 368,
                                "SimulationControl": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Control_Olkkola1993_IV",
                                    "StartTime": 0,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Treatment_Olkkola1993_IV",
                                    "StartTime": 128,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                }
                            }
                        ]
                    },
                    {
                        "Caption": "Erythromycin+Midazolam (Midazolam po)",
                        "Color": "#FF0000",
                        "Symbol": "Circle",
                        "DDIRatios": [
                            {
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 366,
                                "SimulationControl": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Control_Olkkola1993_Oral",
                                    "StartTime": 0,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Treatment_Olkkola1993_Oral",
                                    "StartTime": 128,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 471,
                                "SimulationControl": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Control_Zimmermann1996",
                                    "StartTime": 0,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Treatment_Zimmermann1996",
                                    "StartTime": 97.5,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 362,
                                "SimulationControl": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Control_Okudaira2007_EM0",
                                    "StartTime": 0,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Treatment_Okudaira2007_EM2",
                                    "StartTime": 25,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 363,
                                "SimulationControl": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Control_Okudaira2007_EM0",
                                    "StartTime": 0,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Treatment_Okudaira2007_EM4",
                                    "StartTime": 73,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 364,
                                "SimulationControl": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Control_Okudaira2007_EM0",
                                    "StartTime": 0,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Erythromycin-Midazolam-DDI",
                                    "Simulation": "DDI_Treatment_Okudaira2007_EM7",
                                    "StartTime": 145,
                                    "EndTime": 9999,
                                    "TimeUnit": "h"
                                }
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "Inputs": [
        {
            "Project": "Midazolam",
            "Name": "Midazolam",
            "Type": "Compound",
            "SectionId": 11
        },
        {
            "Project": "Erythromycin",
            "Name": "Erythromycin",
            "Type": "Compound",
            "SectionId": 16
        },
        {
            "Project": "Rifampicin",
            "Name": "Rifampicin",
            "Type": "Compound",
            "SectionId": 21
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "Introduction",
            "Content": "Content/Empty.md",
            "Sections": [
                {
                    "Id": 2,
                    "Title": "Objective",
                    "Content": "Content/Qualification_DDI_CYP3A4_objective.md"
                },
                {
                    "Id": 3,
                    "Title": "CYP3A4 DDI Network",
                    "Content": "Content/Qualification_DDI_CYP3A4_network_description.md"
                },
                {
                    "Id": 4,
                    "Title": "Qualification Workflow",
                    "Content": "Content/Qualification_Workflow.md"
                }
            ]
        },
        {
            "Id": 5,
            "Title": "Qualification of Use Case CYP3A4-mediated DDI",
            "Content": "Content/Empty.md"
        },
        {
            "Id": 6,
            "Title": "Appendix",
            "Content": "Content/Empty.md",
            "Sections": [
                {
                    "Id": 7,
                    "Title": "Open Systems Pharmacology Suite (OSPS) Introduction",
                    "Content": "Content/OSPS_Introduction.md"
                },
                {
                    "Id": 8,
                    "Title": "Mathematical Implementation of drug-drug interactions",
                    "Content": "Content/Mathematical_Implementation_of_DDI.md"
                },
                {
                    "Id": 9,
                    "Title": "Evaluation of victim and perpetrator models",
                    "Content": "Content/Intro_evaluation_victim_and_perpetrator_models.md",
                    "Sections": [
                        {
                            "Id": 10,
                            "Title": "Midazolam Model",
                            "Content": "Content/Intro_Midazolam-model.md",
                            "Sections": [
                                {
                                    "Id": 11,
                                    "Title": "Midazolam input parameters",
                                    "Content": "Content/Intro_Input_parameters.md"
                                },
                                {
                                    "Id": 12,
                                    "Title": "Midazolam model evaluation",
                                    "Content": "Content/Intro_Model_evaluation.md",
                                    "Sections": [
                                        {
                                            "Id": 13,
                                            "Title": "Midazolam concentration-time profiles",
                                            "Content": "Content/Intro_Model_evaluation_CTprofiles.md"
                                        },
                                        {
                                            "Id": 14,
                                            "Title": "Midazolam overall goodness of fit",
                                            "Content": "Content/Intro_Model_evaluation_GOF.md"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "Id": 15,
                            "Title": "Erythromycin Model",
                            "Content": "Content/Intro_Itraconazole-model.md",
                            "Sections": [
                                {
                                    "Id": 16,
                                    "Title": "Erythromycin input parameters",
                                    "Content": "Content/Intro_Input_parameters.md"
                                },
                                {
                                    "Id": 17,
                                    "Title": "Erythromycin model evaluation",
                                    "Content": "Content/Intro_Model_evaluation.md",
                                    "Sections": [
                                        {
                                            "Id": 18,
                                            "Title": "Erythromycin concentration-time profiles",
                                            "Content": "Content/Intro_Model_evaluation_CTprofiles.md"
                                        },
                                        {
                                            "Id": 19,
                                            "Title": "Erythromycin overall goodness of fit",
                                            "Content": "Content/Intro_Model_evaluation_GOF.md"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "Id": 20,
                    "Title": "Evaluation of DDI network (coupled perpetrator / victim simulations)",
                    "Content": "Content/Intro_evaluation_DDI_network.md",
                    "Sections": [
                        {
                            "Id": 21,
                            "Title": "Erythromycin-midazolam DDI",
                            "Content": "Content/Intro_Itraconazole-midazolam_DDI.md"
                        }
                    ]
                }
            ]
        }
    ]
}